GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire September 16, 2025 Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Grocery Outlet (GO) To Contact Him Directly To Discuss Their Options If […]

MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals

MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced positive results demonstrating

Highland Copper Receives Letter of Interest from Export-Import Bank of the United States for Up to US$250 Million Debt Financing to Advance Copperwood Project

(TSX-V:HI),(OTC US:HDRSF),(Other OTC:HDRSF), VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) — Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) (“Highland” or the “Company”) is pleased to announce it has received a non-binding Letter of Interest (“LOI”) from the Export-Import Bank of the United States (“EXIM”) for potential debt financing of up to US$250 million

Humanoid Global Announces Commitment to a Strategic Investment in Agility Robotics, Developers of One of the World’s First Commercially Deployed Humanoid Robot

(CNSX:ROBO),(Boerse Frankfurt – Freiverkehr:0XM1),(Pinksheets:TRMNF),(PinkSheets:TRMNF),(Pinksheets:RBOHF),(PinkSheets:RBOHF), Vancouver, BC & Salem, Oregon, Sept. 16, 2025 (GLOBE NEWSWIRE) — Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company“) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that

Digi Power X Issues Letter to Shareholders

(TSX-V:DGHI),(NASDAQ:DGHI),(NASDAQ:DGXX),(TSX-V:DGX),(NASDAQ:SMCI), This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX / TSXV: DGX), an

Beneficient Granted Listing Extension by Nasdaq

(NASDAQ:BENF), DALLAS, Sept. 16, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated September 9, 2025, the Company was notified by The

Annovis Reports Peer-Reviewed Publication Highlighting Pharmacokinetics of Novel Crystal Buntanetap

(NYSE:ANVS), MALVERN, Pa., Sept. 16, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced the publication of a new article in a peer-reviewed journal Biomolecules, which describes the

Safe Software Launches 24/7 Support For FME Users Worldwide

Surrey, BC & London, UK, Sept. 16, 2025 (GLOBE NEWSWIRE) — Safe Software (Safe), the creator of FME, the only All-Data, Any-AI enterprise integration platform on the market with true support for spatial data today announced the expansion of its Premium Extended Support program with the launch of global 24/7 coverage. This offering ensures that

Spectral Medical Announces Publication of EDEN Observational Study

(TSX:EDT), TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today highlighted newly published findings in Critical Care Explorations that define endotoxic septic shock (“ESS”) as a distinct and deadly form of septic shock. The prospective,

Scroll to Top